US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Parnell Pharmaceuticals

1.00

0.0000

Volume:- -

Turnover:- -

Market Cap:13.28M

PE:-1.30

High:1.00

Open:1.00

Low:1.00

Close:1.00

52wk High:3.95

52wk Low:0.6500

Shares:13.28M

Float Shares:6.67M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7700

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Parnell Pharmaceuticals

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.parnell.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Parnell Pharmaceuticals Holdings Ltd, a veterinary pharmaceutical company, focuses on developing, manufacturing, and commercializing various animal health solutions. The company operates through four segments: Companion Animal, Production Animal U.S, Production Animal Rest of World, and Manufacturing Operations. It markets various products, which include estroPLAN and GONAbreed reproductive hormone products for breeding programs in dairy and beef cows; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; Glyde, a nutraceutical product aids for the treatment of OA in dogs; and Tergive, an injectable non-steroidal anti-inflammatory drug that contains carprofen. The company is also developing various products consisting of PAR121 for bone-related diseases and injuries in dogs, cats, and horses; PAR081 for general anesthesia and sedation in dogs and cats, as well as in humans; PAR101 for laminitis in horses and diabetes in dogs; PAR061, an injectable antimicrobial prodrug for mastitis in cattle; GONADOPRO for cattle fertility; and PAR122 for atopic dermatitis and other dermatological conditions. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PARN/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"PARN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PARN\",,,,,undefined,":{"symbol":"PARN","market":"US","secType":"STK","nameCN":"Parnell Pharmaceuticals","latestPrice":1,"timestamp":1483650000000,"preClose":1,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":6670000,"shares":13283722,"eps":-0.77,"marketStatus":"Delisted","change":0,"latestTime":"01-05 16:00:00 EST","open":1,"high":1,"low":1,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.77,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1403064000000,"exchange":"NASDAQ","adjPreClose":1,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PARN\",,,,,undefined,":{"symbol":"PARN","floatShares":6670000,"roa":"--","roe":"--","lyrEps":0,"shares":13283722,"dividePrice":0,"high":1,"amplitude":0,"preClose":1,"low":1,"week52Low":0.65,"pbRate":"--","week52High":3.95,"institutionHeld":0,"latestPrice":1,"eps":-0.77,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.77,"open":1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PARN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-11-02","symbol":"PARN","fiscalQuarterEnding":null,"expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1478059200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2016-08-04","symbol":"PARN","fiscalQuarterEnding":null,"expectedEps":-0.54,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1470283200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-04-22","symbol":"PARN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1461297600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-02-24","symbol":"PARN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1456290000000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2015-10-21","symbol":"PARN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1445400000000,"reportTimeType":"pre","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PARN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PARN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.parnell.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Parnell Pharmaceuticals Holdings Ltd, a veterinary pharmaceutical company, focuses on developing, manufacturing, and commercializing various animal health solutions. The company operates through four segments: Companion Animal, Production Animal  U.S, Production Animal  Rest of World, and Manufacturing Operations. It markets various products, which include estroPLAN and GONAbreed reproductive hormone products for breeding programs in dairy and beef cows; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; Glyde, a nutraceutical product aids for the treatment of OA in dogs; and Tergive, an injectable non-steroidal anti-inflammatory drug that contains carprofen. The company is also developing various products consisting of PAR121 for bone-related diseases and injuries in dogs, cats, and horses; PAR081 for general anesthesia and sedation in dogs and cats, as well as in humans; PAR101 for laminitis in horses and diabetes in dogs; PAR061, an injectable antimicrobial prodrug for mastitis in cattle; GONADOPRO for cattle fertility; and PAR122 for atopic dermatitis and other dermatological conditions. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.","exchange":"NASDAQ","name":"Parnell Pharmaceuticals","nameEN":"Parnell Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PARN\",market:\"US\",,,undefined,":null}}